A novel mechanism of resistance to penicillin-gentamicin synergism in Streptococcus faecalis

J Infect Dis. 1980 Jan;141(1):81-6. doi: 10.1093/infdis/141.1.81.

Abstract

A patient with enterococcal endocarditis, who relapsed after repeated courses of apparently adequate treatment with ampicillin plus gentamicin, was subsequently cured with ampicillin-tobramycin therapy. The organisms isolated from this patient were strains of Streptococcus faecalis that were resistant to penicillin (or ampicillin)-gentamicin synergism but not to penicillin (or ampicillin)-tobramycin synergism. The mechanism of resistance in these strains appears to be related to a specific defect in the intracellular uptake of gentamicin (but not tobramycin) in the presence of penicillin.

Publication types

  • Case Reports

MeSH terms

  • Dose-Response Relationship, Drug
  • Drug Synergism
  • Endocarditis, Bacterial / drug therapy*
  • Enterococcus faecalis / classification
  • Enterococcus faecalis / drug effects
  • Enterococcus faecalis / isolation & purification
  • Female
  • Gentamicins / metabolism
  • Gentamicins / therapeutic use*
  • Humans
  • Microbial Sensitivity Tests
  • Middle Aged
  • Penicillins / metabolism
  • Penicillins / therapeutic use*
  • Streptococcal Infections / drug therapy*
  • Tobramycin / metabolism

Substances

  • Gentamicins
  • Penicillins
  • Tobramycin